AVTRHealthcare · Medical Instruments & SuppliesThe 15 Wall Street analysts covering Avantor, Inc. hold a median 12-month price target of $15 — -12.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 85 of 100 as at 26 Oct 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Avantor, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (94): The share count has been shrinking and the company is not leaning on new borrowing.
Growth (40): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AVTR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −12.4% from it.
Of the 20 most recent actions, 11 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Oct 2026 | Morgan Stanley | Maintains | Equal-Weight | $14 → $15 |
| 13 Oct 2026 | TD Cowen | Maintains | Hold | $15 → $17 |
| 7 Oct 2026 | Barclays | Maintains | Underweight | $13 → $15 |
| 9 Sept 2026 | UBS | Maintains | Neutral | — |
| 9 Sept 2026 | UBS | Maintains | Neutral | $11 → $16 |
| 30 July 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 30 July 2026 | Evercore ISI Group | Maintains | In-Line | $11 → $14 |
| 30 July 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 30 July 2026 | Morgan Stanley | Maintains | Equal-Weight | $10 → $14 |
| 30 July 2026 | RBC Capital | Maintains | Sector Perform | $9.00 → $14 |
| 30 July 2026 | RBC Capital | Maintains | Sector Perform | — |
| 30 July 2026 | Stifel | Maintains | Hold | $8.00 → $15 |
| 30 July 2026 | Stifel | Maintains | Hold | — |
| 30 July 2026 | Wells Fargo | Maintains | Overweight | — |
| 30 July 2026 | Wells Fargo | Maintains | Overweight | $14 → $16 |
| 8 July 2026 | Citigroup | Maintains | Neutral | $9.00 → $11 |
| 8 July 2026 | Citigroup | Maintains | Neutral | — |
| 6 July 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 6 July 2026 | Evercore ISI Group | Maintains | In-Line | $8.00 → $11 |
| 26 June 2026 | Bernstein | Reinstates | Market Perform | $11 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AVTR appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 27 Oct 2026, Avantor, Inc. returned +13.4% against +13.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 46% of US stocks
Cheaper than 54% of US stocks
Cheaper than 41% of US stocks
Cheaper than 20% of US stocks
Higher than 29% of US stocks
Higher than 13% of US stocks
Higher than 36% of US stocks
Higher than 59% of US stocks
Higher than 21% of US stocks
Higher than 36% of US stocks
Higher than 63% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Avantor, Inc. has a market value of $11.7B and an enterprise value of $15.1B.
Revenue in the twelve months to 30 June 2026: $6.6B. The latest quarter grew 0.5% year on year.
Net income over the same four quarters: −$578.0M, a −8.8% net margin.
Diluted earnings per share, trailing twelve months: $−0.84.
Free cash flow in the twelve months to 30 June 2026: $454.7M, after $142.3M of capital spending.
Avantor, Inc. spent $79.6M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 14.9×; forward P/E: 19.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Avantor, Inc. employs 13,500 people — $486K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Avantor, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Avantor announced that Mikey Santiago has joined the company as its new Chief Information Officer.
Why it matters — AVTR watchers may note the leadership appointment as part of the company’s corporate updates.
Longleaf Partners said market confidence is returning in Avantor’s ability to grow organically and in CEO Emmanuel Ligner’s turnaround plan.
Why it matters — The update highlights improving market confidence in Avantor’s growth prospects and turnaround efforts.
Avantor’s improving commercial execution and strength in specialty products, along with a raised 2026 outlook, point to recovery potential. The excerpt also notes lingering demand challenges.
Why it matters — AVTR watchers may weigh signs of operational improvement and the higher outlook against continued demand challenges.
Zacks Investment Research compares Viatris (VTRS) and Avantor (AVTR) as potential value-investing options in the Medical Services sector.
Why it matters — The item puts AVTR in a direct comparison for investors assessing value stocks in its sector.
Avantor announced it will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026, followed by a conference call at 8:00 a.m. the same day.
Why it matters — The scheduled earnings release and conference call give Avantor watchers the confirmed date and time to anticipate the company's third-quarter performance update.
The 15 Wall Street analysts covering Avantor, Inc. have a median 12-month price target of $15, with estimates ranging from $13 to $19. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 15 analysts covering Avantor, Inc., 2 rate it a Buy, 12 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Avantor, Inc. 85 out of 100 across roughly 4,600 US stocks as at 26 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 26 Oct 2026, Avantor, Inc. ranks 85 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (94 of 100).
No one can know that. What the data says: the median 12-month target from 15 analysts implies -12.4% from the last close, and Ticker Nerd's factor model ranks Avantor, Inc. 85 out of 100 as at 26 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Avantor, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVTR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $19 over the next 12 months.
Avantor, Inc. returned +13.4% over the 12 months to 27 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries.
The most recent item we track (PRNewsWire, 26 Oct 2026): "Avantor appoints new Chief Information Officer". Avantor announced that Mikey Santiago has joined the company as its new Chief Information Officer.
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries. Its portfolio includes laboratory chemicals, reagents, consumables, equipment, instrumentation, single-use bioprocessing components, and specialty services that support research, development, production, and quality control. The company also provides customized materials and procurement solutions for highly regulated environments, helping laboratories and production teams maintain consistent workflows across the scientific supply chain. Avantor serves customers across the Americas, Europe, Asia, the Middle East, and Africa, with operations centered in Radnor, Pennsylvania.
CEO Mr. Emmanuel Ligner · 13,500 employees · United States · https://www.avantorsciences.com
